| Gracy Woods Ii Living Center | |
| 12042 Bittern Hollow, Austin, Texas 78758 | |
| (512) 730-2100 | |
| Name | Gracy Woods Ii Living Center |
|---|---|
| Location | 12042 Bittern Hollow, Austin, Texas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 91 |
| Occupancy Rate | 80.55% |
| Medicare ID (CCN) | 675914 |
| Legal Business Name | Coryell County Memorial Hospital Authority |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1013321579 |
| Organization Name | GRACY WOODS HEALTHCARE LLC |
| Doing Business As | GRACY WOODS II LIVING CENTER |
| Address | 12042 Bittern Holw, Austin, TX 78758 |
| Phone Number | 512-730-2100 |
News Archive
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any future bioterrorist incident. That's the conclusion of a sweeping overview of scientific research on medical technology to combat the anthrax threat. It appears in ACS' bi-weekly Journal of Medicinal Chemistry.
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.
› Verified 9 days ago
| NPI Number | 1467512004 |
| Organization Name | PM MANAGEMENT-AUSTIN NC II, LLC |
| Doing Business As | GRACY WOODS II LIVING CENTER |
| Address | 12042 Bittern Holw, Austin, TX 78758 |
| Phone Number | 512-228-3350 |
News Archive
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any future bioterrorist incident. That's the conclusion of a sweeping overview of scientific research on medical technology to combat the anthrax threat. It appears in ACS' bi-weekly Journal of Medicinal Chemistry.
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.
› Verified 9 days ago
| NPI Number | 1689114498 |
| Organization Name | CORYELL COUNTY MEMORIAL HOSPITAL AUTHORITY |
| Doing Business As | GRACY WOODS II LIVING CENTER |
| Address | 12042 Bittern Holw, Austin, TX 78758 |
| Phone Number | 512-730-2100 |
News Archive
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any future bioterrorist incident. That's the conclusion of a sweeping overview of scientific research on medical technology to combat the anthrax threat. It appears in ACS' bi-weekly Journal of Medicinal Chemistry.
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any future bioterrorist incident. That's the conclusion of a sweeping overview of scientific research on medical technology to combat the anthrax threat. It appears in ACS' bi-weekly Journal of Medicinal Chemistry.
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $6923 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.11 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.59 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 48.86 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.35 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 13.13 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.69 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.26 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.21 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.06 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 11.59 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.35 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.16 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.16 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.32 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 94.62 | 82.93 |
News Archive
The 2001 anthrax attacks in the United States are fostering development of a new generation of vaccines, antibiotics, and other medications to protect people against the potentially deadly bacteria in any future bioterrorist incident. That's the conclusion of a sweeping overview of scientific research on medical technology to combat the anthrax threat. It appears in ACS' bi-weekly Journal of Medicinal Chemistry.
A new blood test provides a fast and accurate tool to diagnose tuberculosis in children, a new proof-of-concept study shows. The newly developed test (TAM-TB assay) is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
The bill rushed through the House of Representatives by voice vote yesterday to patch Medicare regulations includes a highly controversial provision that has nothing to do with Medicare, and that would subject people in crisis to forced treatment.
In an article published in Nature Genetics today, scientists at the ALS Therapy Development Institute describe how they have linked an unbiased gene expression profiling effort to the identification and successful preclinical testing of a potential novel therapeutic for amyotrophic lateral sclerosis.
› Verified 9 days ago
Heritage Park Rehabilitation And Skilled Nursing C Location: 2806 Real St, Austin, Texas 78722 Phone: (512) 474-1411 | |
Austin Wellness & Rehabilitation Location: 11406 Rustic Rock Drive, Austin, Texas 78750 Phone: (512) 335-5028 | |
Retirement And Nursing Center Austin Location: 6909 Burnet Ln, Austin, Texas 78757 Phone: (512) 452-5719 | |
Brush Country Nursing And Rehabilitation Location: 6500 Brush Country Rd, Austin, Texas 78749 Phone: (512) 892-5774 | |
Austin Healthcare And Rehabilitation Center Location: 3509 Rogge Ln, Austin, Texas 78723 Phone: (512) 926-2070 |